Takeda, Lilly Rejected by Supreme Court on Actos Fraud Lawsuit

The U.S. Supreme Court cleared the way for a multibillion-dollar racketeering lawsuit that accuses Takeda Pharmaceutical Co. and Eli Lilly & Co. of marketing the Actos diabetes drug without disclosing its link to bladder cancer. In a one-line order Monday, …

Read the full article →

Share:

More Posts

Send Us A Message